Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
FDA
Jun 26, 2024, 09:54 |
Insight
Miguel Bronchud: How often is post-recurrence treatment reported in adjuvant and neoadjuvant oncology randomized clinical trials?
Miguel Bronchud, Co-Founder of Regenerative Medicine Solutions, shared on LinkedIn: "Clinical trials- not “real life”? They…
Jun 26, 2024, 03:52 |
Opinion
Alexandros Alexandropoulos: Some thoughts on Multiple Melanoma clinical trials practice and restrictions
Alexandros Alexandropoulos, Hematologist at Laiko General Hospital, shared a post on X: "Some thoughts on Multiple…
Jun 25, 2024, 15:51 |
Career
Agenus Regulatory is hiring Director of Regulatory Affairs
Eric J. Olson, Global Head of Regulatory at Agenus, shared on LinkedIn: "Agenus Regulatory is…
Jun 25, 2024, 07:47 |
Blog
Mark Lewis: It is UNACCEPTABLE to treat mCRC without knowing these biomarker
Mark Lewis shared a post by FDA Oncology on X, adding the following: . “We…
Jun 25, 2024, 04:43 |
Insight
Pedro C. Barata: Happy to bring new technology and therapies to patients at University Hospitals
Pedro C. Barata, Miggo Family Endowment Chair in Clinical Research at University Hospitals, shared University…
Jun 25, 2024, 03:26 |
Blog
Vivek Subbiah: Such a delight to have our paper published in a journal with the highest impact factor
Vivek Subbiah shared on LinkedIn: "2023 Impact factors for all journals are out!!! CA: A Cancer…
Jun 24, 2024, 15:19 |
Insight
Vivek Subbiah: Precision therapy with ALK inhibitor in ALCL
Vivek Subbiah shared on X: . "Precision therapy with anaplastic lymphoma…
Jun 24, 2024, 13:16 |
Insight
Hagop Kantarjian: NPM1-mutant myeloid neoplasms should be treated with AML-type treatment
Hagop Kantarjian shared on X: . "NPM1-mutant myeloid…
Jun 23, 2024, 10:44 |
Blog
IV vs Subcutaneous amivantamab in EGFR NSCLC
Eric K. Singhi shared a post by Stephen V Liu, on X: "Absolutely agree with this! Compared with…
Jun 23, 2024, 04:42 |
Drugs
Tanja Obradovich: This month marks Keytruda reaching 40 approved indications in the US
Tanja Obradovich shared on LinkedIn: “This month (as of June 17th) marks Keytruda reaching 40…
50
51
52
53
54
All:
948
Posts:
511 - 520
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube